182 related articles for article (PubMed ID: 25262178)
1. Therapeutic effects of add-on low-dose dextromethorphan plus valproic acid in bipolar disorder.
Chen SL; Lee SY; Chang YH; Chen PS; Lee IH; Wang TY; Chen KC; Yang YK; Hong JS; Lu RB
Eur Neuropsychopharmacol; 2014 Nov; 24(11):1753-9. PubMed ID: 25262178
[TBL] [Abstract][Full Text] [Related]
2. The effects of add-on low-dose memantine on cytokine levels in bipolar II depression: a 12-week double-blind, randomized controlled trial.
Lee SY; Chen SL; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang YS; Wang LJ; Lee IH; Wang TY; Yeh TL; Yang YK; Hong JS; Lu RB
J Clin Psychopharmacol; 2014 Jun; 34(3):337-43. PubMed ID: 24717258
[TBL] [Abstract][Full Text] [Related]
3. The DRD2/ANKK1 gene is associated with response to add-on dextromethorphan treatment in bipolar disorder.
Lee SY; Chen SL; Chang YH; Chen SH; Chu CH; Huang SY; Tzeng NS; Wang CL; Lee IH; Yeh TL; Yang YK; Lu RB
J Affect Disord; 2012 May; 138(3):295-300. PubMed ID: 22326841
[TBL] [Abstract][Full Text] [Related]
4. Genotype variant associated with add-on memantine in bipolar II disorder.
Lee SY; Chen SL; Chang YH; Chen SH; Chu CH; Huang SY; Tzeng NS; Wang CL; Wang LJ; Lee IH; Yeh TL; Yang YK; Hong JS; Lu RB
Int J Neuropsychopharmacol; 2014 Feb; 17(2):189-97. PubMed ID: 24103632
[TBL] [Abstract][Full Text] [Related]
5. Comparing clinical responses and the biomarkers of BDNF and cytokines between subthreshold bipolar disorder and bipolar II disorder.
Wang TY; Lee SY; Chen SL; Chang YH; Wang LJ; Chen PS; Chen SH; Chu CH; Huang SY; Tzeng NS; Li CL; Chung YL; Hsieh TH; Lee IH; Chen KC; Yang YK; Hong JS; Lu RB
Sci Rep; 2016 Jun; 6():27431. PubMed ID: 27270858
[TBL] [Abstract][Full Text] [Related]
6. Add-on memantine to valproate treatment increased HDL-C in bipolar II disorder.
Lee SY; Chen SL; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang YS; Wang LJ; Lee IH; Yeh TL; Yang YK; Lu RB; Hong JS
J Psychiatr Res; 2013 Oct; 47(10):1343-8. PubMed ID: 23870798
[TBL] [Abstract][Full Text] [Related]
7. Add-On Memantine Treatment for Bipolar II Disorder Comorbid with Alcohol Dependence: A 12-Week Follow-Up Study.
Lee SY; Wang TY; Chen SL; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang LJ; Lee IH; Chen KC; Yang YK; Hong JS; Lu RB
Alcohol Clin Exp Res; 2018 Jun; 42(6):1044-1050. PubMed ID: 29656414
[TBL] [Abstract][Full Text] [Related]
8. Combination of dextromethorphan and memantine in treating bipolar spectrum disorder: a 12-week double-blind randomized clinical trial.
Lee SY; Wang TY; Chen SL; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang LJ; Lee IH; Chen KC; Yang YK; Hong JS; Lu RB
Int J Bipolar Disord; 2020 Mar; 8(1):11. PubMed ID: 32115672
[TBL] [Abstract][Full Text] [Related]
9. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
Juruena MF; Ottoni GL; Machado-Vieira R; Carneiro RM; Weingarthner N; Marquardt AR; Fleig SS; Broilo L; Busnello EA
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):94-9. PubMed ID: 19007842
[TBL] [Abstract][Full Text] [Related]
10. A placebo-controlled trial of dextromethorphan as an adjunct in opioid-dependent patients undergoing methadone maintenance treatment.
Lee SY; Chen SL; Chang YH; Chu CH; Chen SH; Chen PS; Huang SY; Tzeng NS; Wang LJ; Lee IH; Wang TY; Chen KC; Yang YK; Hong JS; Lu RB
Int J Neuropsychopharmacol; 2015 Feb; 18(7):pyv008. PubMed ID: 25716777
[TBL] [Abstract][Full Text] [Related]
11. Serum protein levels of brain-derived neurotrophic factor and tropomyosin-related kinase B in bipolar disorder: effects of mood stabilizers.
Huang TL; Hung YY; Lee CT; Chen RF
Neuropsychobiology; 2012; 65(2):65-9. PubMed ID: 22222435
[TBL] [Abstract][Full Text] [Related]
12. The COMT Val158Met Polymorphism Is Associated With Response to Add-on Dextromethorphan Treatment in Bipolar Disorder.
Lee SY; Chen SL; Wang TY; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang LJ; Lee IH; Chen KC; Yang YK; Lu RB
J Clin Psychopharmacol; 2017 Feb; 37(1):94-98. PubMed ID: 27930497
[TBL] [Abstract][Full Text] [Related]
13. Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week study.
de Sousa RT; van de Bilt MT; Diniz BS; Ladeira RB; Portela LV; Souza DO; Forlenza OV; Gattaz WF; Machado-Vieira R
Neurosci Lett; 2011 Apr; 494(1):54-6. PubMed ID: 21362460
[TBL] [Abstract][Full Text] [Related]
14. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
McIntyre RS; Konarski JZ; Jones M; Paulsson B
J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773
[TBL] [Abstract][Full Text] [Related]
15. The correlation between plasma brain-derived neurotrophic factor and cognitive function in bipolar disorder is modulated by the BDNF Val66Met polymorphism.
Lee SY; Wang TY; Chen SL; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang LJ; Lee IH; Chen KC; Yang YK; Yang YH; Lu RB; Chen CS
Sci Rep; 2016 Dec; 6():37950. PubMed ID: 27905499
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of combination of risperidone and haloperidol with divalproate in patients with acute mania.
Ouyang WC; Hsu MC; Yeh IN; Kuo CC
Int J Psychiatry Clin Pract; 2012 Sep; 16(3):178-88. PubMed ID: 22404731
[TBL] [Abstract][Full Text] [Related]
17. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.
Sussman N; Mullen J; Paulsson B; Vågerö M
J Affect Disord; 2007; 100 Suppl 1():S55-63. PubMed ID: 17383736
[TBL] [Abstract][Full Text] [Related]
18. Is intravenous valproate more efficacious than oral valproate for inpatients with bipolar I disorder with a manic or depressive episode and concomitant symptoms of opposite polarity?
Cuomo A; Barillà G; Cattolico M; Carmellini P; Spiti A; Pozza A; Fagiolini A
Bipolar Disord; 2024 May; 26(3):277-283. PubMed ID: 37957926
[TBL] [Abstract][Full Text] [Related]
19. Carbamazepine and valproate monotherapy: feasibility, relative safety and efficacy, and therapeutic drug monitoring in manic disorder.
Vasudev K; Goswami U; Kohli K
Psychopharmacology (Berl); 2000 May; 150(1):15-23. PubMed ID: 10867972
[TBL] [Abstract][Full Text] [Related]
20. Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial.
Sachs GS; Vanderburg DG; Karayal ON; Kolluri S; Bachinsky M; Cavus I
J Clin Psychiatry; 2012 Nov; 73(11):1412-9. PubMed ID: 23218157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
